Literature DB >> 16195404

Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism.

Kimberly J Land1, Prathyusha Gudapati, Mark H Kaplan, Gattadahalli S Seetharamaiah.   

Abstract

T helper type 1 (Th1) and Th2 cells have critical roles in the development of cell-mediated and humoral immune responses, respectively. This division of function predicts that Th1 cells mediate inflammatory diseases and Th2 cells promote antibody (Ab)-mediated autoimmunity. Our previous studies using HEK-293 cells expressing the extracellular domain of the TSH receptor (TSHR) showed that Stat4-/- mice, which lack Th1 cells, are susceptible, whereas Stat6-/- mice, which lack Th2 cells, are resistant to the induction of Graves' hyperthyroidism. To investigate the role of Stat4 and Stat6 genes in other murine models of hyperthyroidism, we injected wild-type BALB/c, Stat4-/-, and Stat6-/- mice with an adenovirus expressing amino acid residues 1-289 of TSHR (TSHR-289-ad or 289-ad). The viral system induces a much stronger immune response with much more rapid onset of disease. Our results showed that 56% of wild-type, 75% of Stat4-/-, and 39% of Stat6-/- mice developed hyperthyroidism. Hyperthyroid mice exhibited thyroid stimulatory Abs. The Stat4-/- mice developed a higher incidence and greater severity of hyperthyroidism compared with wild-type and Stat6-/- mice. BALB/c and Stat4-/- mice showed significantly higher TSHR Abs of the IgG1 subclass and IL-4 compared with Stat6-/- mice. In contrast, Stat6-/- mice had predominantly the IgG2a subclass of TSHR Ab and produced significantly higher amounts of IFN-gamma than BALB/c and Stat4-/- mice. All hyperthyroid mice showed enlarged thyroid glands with hyperactivity. These results suggest that in the TSHR-289-ad model, the Th2 cells are more efficient in mediating disease, but in the absence of Th2 cells, Th1 cells may still initiate a reduced incidence of Graves' hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195404     DOI: 10.1210/en.2005-1031

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 2.  Insight Into Mouse Models of Hyperthyroidism.

Authors:  Mengyu Zhang; Wen Jiang; Ganghua Lu; Ru Wang; Zhongwei Lv; Dan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-22       Impact factor: 6.055

Review 3.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

Review 4.  Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Terry J Smith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-10       Impact factor: 3.243

Review 5.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-01-22       Impact factor: 19.871

6.  Contribution of the STAT4 rs7574865 gene polymorphism to the susceptibility to autoimmune thyroiditis in healthy Turk population and psoriatic subgroups.

Authors:  Meliha M Hiz; Sevilay Kılıç; Selda Işık; Zerrin Ogretmen; Fatma Silan
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

7.  STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia.

Authors:  Xuechao Jiang; Bingbing Zha; Xiaoming Liu; Ronghua Liu; Jun Liu; Enyu Huang; Tingting Qian; Jiajing Liu; Zhiming Wang; Dan Zhang; Luman Wang; Yiwei Chu
Journal:  Cell Death Dis       Date:  2016-12-01       Impact factor: 8.469

8.  MiR-363-5p modulates regulatory T cells through STAT4-HSPB1-Notch1 axis and is associated with the immunological abnormality in Graves' disease.

Authors:  Xianlun Yin; Junfeng Ge; Xiurong Ge; Jing Gao; Xinhuan Su; Xiaowei Wang; Qunye Zhang; Zhe Wang
Journal:  J Cell Mol Med       Date:  2021-08-25       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.